DIAGONAL BIO AB Aktie - Unternehmensdaten & Kurse - SE0015961826 | MoneyPeak

DIAGONAL BIO AB

Share · SE0015961826 · A3CR6X (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 94,70 %

Shares Float 1,07 B

Shares Outstanding 1,13 B

Company Profile for DIAGONAL BIO AB Share

Diagonal Bio AB operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was founded in 2020 and is headquartered in Lund, Sweden.

Get up to date insights from finAgent about DIAGONAL BIO AB

Company Data

Name DIAGONAL BIO AB

Company Diagonal Bio AB (publ)

Website https://diagonalbio.com

Primary Exchange

Frankfurt

WKN A3CR6X

ISIN SE0015961826

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Karin Wehlin MBA

Market Capitalization 16 Mio

Country Sweden

Currency EUR

Employees 0,0 T

Address The Spark, 223 81 Lund

IPO Date 2021-07-16

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	DIABIO.ST
Frankfurt	9F1.F

More Shares

Investors who hold DIAGONAL BIO AB also have the following shares in their portfolio:

CANADIAN IMPERIAL BANK OF COMMERCE CBL17 2.350% COV BDS 27/07/22 (144A) Bond

ROYAL BANK OF CANADA 0.875% CVD BDS 17/06/22 RULE144A Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025